作者
Meng-Ju Wu,Lei Shi,Juan Dubrot,Joshua Merritt,Vindhya Vijay,Ting-Yu Wei,Emily Kessler,Kira E Olander,Ramzi Adil,Amaya Pankaj,Krishna S. Tummala,Vajira Weeresekara,Yuanli Zhen,Qibiao Wu,Meiqi Luo,William Shen,María García-Beccaria,Mirian Fernandez-Vaquero,Christine Hudson,Sebastien Ronseaux,Yi Sun,Rodrigo Saad-Berreta,Russell W. Jenkins,Tong Wang,Mathias Heikenwalder,Cristina R. Ferrone,Lipika Goyal,Brandon Nicolay,Vikram Deshpande,Rahul M. Kohli,Hongwu Zheng,Robert T. Manguso,Nabeel Bardeesy
摘要
The efficacy of mutant IDH1 inhibition in a genetically engineered mouse model of cholangiocarcinoma is mediated by stimulation of cytotoxic T-cell function and derepression of TET2 in tumor cells, which epigenetically resensitizes tumor cells to IFNγ.